Literature DB >> 28541542

Reducing stock-outs of essential tuberculosis medicines: a system dynamics modelling approach to supply chain management.

L Bam1, Z M McLaren2, E Coetzee1, K H von Leipzig1.   

Abstract

The under-performance of supply chains presents a significant hindrance to disease control in developing countries. Stock-outs of essential medicines lead to treatment interruption which can force changes in patient drug regimens, drive drug resistance and increase mortality. This study is one of few to quantitatively evaluate the effectiveness of supply chain policies in reducing shortages and costs. This study develops a systems dynamics simulation model of the downstream supply chain for amikacin, a second-line tuberculosis drug using 10 years of South African data. We evaluate current supply chain performance in terms of reliability, responsiveness and agility, following the widely-used Supply Chain Operation Reference framework. We simulate 141 scenarios that represent different combinations of supplier characteristics, inventory management strategies and demand forecasting methods to identify the Pareto optimal set of management policies that jointly minimize the number of shortages and total cost. Despite long supplier lead times and unpredictable demand, the amikacin supply chain is 98% reliable and agile enough to accommodate a 20% increase in demand without a shortage. However, this is accomplished by overstocking amikacin by 167%, which incurs high holding costs. The responsiveness of suppliers is low: only 57% of orders are delivered to the central provincial drug depot within one month. We identify three Pareto optimal safety stock management policies. Short supplier lead time can produce Pareto optimal outcomes even in the absence of other optimal policies. This study produces concrete, actionable guidelines to cost-effectively reduce stock-outs by implementing optimal supply chain policies. Preferentially selecting drug suppliers with short lead times accommodates unexpected changes in demand. Optimal supply chain management should be an essential component of national policy to reduce the mortality rate.
© The Author 2017. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Supply chain; amikacin; drug resistance; essential medicines; multi-drug resistant tuberculosis; stock-outs; system dynamics modelling; tuberculosis

Mesh:

Substances:

Year:  2017        PMID: 28541542     DOI: 10.1093/heapol/czx057

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  7 in total

1.  Monitoring Pharmacy and Test Kit Stocks in Rural Mozambique: U.S. President's Emergency Plan for AIDS Relief Surveillance to Help Prevent Ministry of Health Shortages.

Authors:  Magdalena P Bravo; Meridith Blevins Peratikos; Amina S Muicha; Epifanio Mahagaja; Maria Fernanda Sardella Alvim; Ann F Green; C William Wester; Sten H Vermund
Journal:  AIDS Res Hum Retroviruses       Date:  2020-03-02       Impact factor: 2.205

2.  Sustaining tuberculosis preventive therapy scale-up through direct supportive supervision.

Authors:  S C Meribe; Y Adamu; E Adebayo-Abikoye; I Lawal; I Amazue-Ezeuko; N Okeji; I Okoye; P Agaba; R Nelson; E Lee; L Chittenden
Journal:  Public Health Action       Date:  2020-06-21

3.  Analysis of the Factors Influencing Enterprise and Government Participation in the Medicines Patent Pool Based on System Dynamics Model.

Authors:  Jinjing Zeng; Wende Zhang; Qingming Tang
Journal:  Iran J Public Health       Date:  2018-10       Impact factor: 1.429

4.  Evaluating the quality of routinely reported data on malaria commodity stocks in Guinea, 2014-2016.

Authors:  Yu Sun; Timothée Guilavogui; Alioune Camara; Mohamed Dioubaté; Babacar Deen Toure; Claude Bahati; Marie Paule Fargier; Jessica Butts; Patrick Condo; Abdoulaye Sarr; Mateusz M Plucinski
Journal:  Malar J       Date:  2018-12-07       Impact factor: 2.979

5.  Stock-outs of antiretroviral and tuberculosis medicines in South Africa: A national cross-sectional survey.

Authors:  Bella Hwang; Amir Shroufi; Tinne Gils; Sarah Jane Steele; Anna Grimsrud; Andrew Boulle; Anele Yawa; Sasha Stevenson; Lauren Jankelowitz; Marije Versteeg-Mojanaga; Indira Govender; John Stephens; Julia Hill; Kristal Duncan; Gilles van Cutsem
Journal:  PLoS One       Date:  2019-03-12       Impact factor: 3.240

Review 6.  From behavioural simulation to computer models: how simulation can be used to improve healthcare management and policy.

Authors:  Guillaume Lamé; Rebecca K Simmons
Journal:  BMJ Simul Technol Enhanc Learn       Date:  2020-03-02

7.  A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.

Authors:  Simon Sensalire; Esther Karungi Karamagi Nkolo; Juliana Nabwire; Anna Lawino; Dithan Kiragga; Martin Muhire; Herbert Kadama; Cordelia Katureebe; Proscovia Namuwenge; Joshua Musinguzi; Jacqueline Calnan; Dejene Seyoum
Journal:  AIDS Res Ther       Date:  2020-05-27       Impact factor: 2.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.